Market Overview:
The global OTC pet medication market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing trend of pet ownership, rising awareness about preventive healthcare for pets, and growing demand for over-the-counter (OTC) medications for pets. The global OTC pet medication market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into fleas & ticks removal products, pain relief & arthritis products, dewormers products and others. The pain relief & arthritis product segment is expected to grow at a highest CAGR during the forecast period owing to increasing prevalence of joint problems in pets across different regions worldwide. On the basis of application, the market is divided into dogs & cats applications; birds applications; fish & reptiles applications; and other animals’ applications such as horses etcetera). Among these segments, dogs& cats application held majority share in 2017 due to high prevalence rateof various diseases among them coupled with rising awareness about preventive healthcare measures among dog and cat owners globally .Among all these regions North America held dominant position in terms ot revenue contribution followed by Europein2017 .
Product Definition:
OTC pet medications are those that can be purchased without a prescription from a veterinarian. They include products to treat common conditions such as allergies, fleas, and worms, as well as pain relief and supplements. OTC pet medications are important because they allow pet owners to address common health problems without having to go through the hassle of scheduling an appointment with a veterinarian or waiting in line at a pharmacy.
Fleas & Ticks Removal:
Fleas and ticks are parasitic organisms that live on the blood of animals. They are usually found in moist areas such as forests, fields, meadows and grasslands. The flea has flat body with four legs and is about one-eighth of an inch long while the tick is shaped like a tiny ball with three legs. Fleas can jump up to 25 times their own length while ticks cannot but can remain attached to the host for months at a time feeding off its blood.
Pain Relief & Arthritis:
Pain relief and arthritis are two types of OTC pet medications available in the market. Pain Relief is used for treatment of chronic pain, inflammation & swelling caused by osteoarthritis. On the other hand, Arthritis is a group of disorders that cause cartilage damage leading to pain & stiffness in joints.
Application Insights:
The dogs & cats segment held the largest share of more than 60.0% in 2017. This is attributed to the rising number of pet dogs and cat owners globally, as well as high adoption rates for these animals in countries such as India, China, U.S., Brazil and Australia among others due to low cost associated with them.
The fish & reptiles segment accounted for USD 536 million in 2017 owing to high ownership rates of pet tortoiseshell cats (T Sicily) across Europe and North America regions coupled with rising demand for medicines that specifically target specific ailments affecting these animals without causing any side effects or health problems caused by other drugs not approved by FDA for use on pets including birds and reptiles species.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its dominance over the forecast period as well. This can be attributed to increasing pet ownership, high disposable income of consumers and a large number of animal shelters across the region. Asia Pacific is estimated to witness lucrative growth during the forecast period owing to rising disposable incomes, improving standard of living and increasing awareness about pet healthcare among consumers.
Growth Factors:
- Increasing pet ownership: The global pet population is expected to grow at a CAGR of 3.8% from 2016 to 2020, reaching 862 million by 2020. This growth in the pet population is primarily attributed to the increase in urbanization and disposable income levels of people across the world.
- Rising awareness about preventive healthcare for pets: There has been a rise in awareness among pet owners about preventive healthcare measures for their pets, which is driving demand for OTC pet medications.
- Growing demand for specialty and premium-priced products: The market for specialty and premium-priced OTC pet medications is growing rapidly as consumers are increasingly willing to pay more for quality products that offer better results or added benefits such as convenience or ease of use.
Scope Of The Report
Report Attributes
Report Details
Report Title
OTC Pet Medication Market Research Report
By Type
Fleas & Ticks Removal, Pain Relief & Arthritis, Dewormers, Others
By Application
Dogs & Cats, Birds, Fish & Reptiles, Others
By Companies
Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Zymox, ChloraSeb, Sulfox, Adequan, Dechra Pharmaceuticals PLC, Nutramax Laboratories, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
159
Number of Tables & Figures
112
Customization Available
Yes, the report can be customized as per your need.
Global OTC Pet Medication Market Report Segments:
The global OTC Pet Medication market is segmented on the basis of:
Types
Fleas & Ticks Removal, Pain Relief & Arthritis, Dewormers, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dogs & Cats, Birds, Fish & Reptiles, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer Companion Animal
- Boehringer Ingelheim Animal Health
- Ceva Sante Animale
- Merck Inc.
- Zoetis Inc.
- Elanco
- Virbac SA
- Vetoquinol SA
- Frontline
- Zymox
- ChloraSeb
- Sulfox
- Adequan
- Dechra Pharmaceuticals PLC
- Nutramax Laboratories, Inc.
Highlights of The OTC Pet Medication Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fleas & Ticks Removal
- Pain Relief & Arthritis
- Dewormers
- Others
- By Application:
- Dogs & Cats
- Birds
- Fish & Reptiles
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the OTC Pet Medication Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
OTC pet medication is a term used to describe medications that are not typically prescribed by a veterinarian, but can be purchased over the counter. These medications may be used to treat common ailments in pets, such as fleas and ticks, or for general health maintenance.
Some of the major companies in the otc pet medication market are Bayer Companion Animal, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Merck Inc., Zoetis Inc., Elanco, Virbac SA, Vetoquinol SA, Frontline, Zymox, ChloraSeb, Sulfox, Adequan, Dechra Pharmaceuticals PLC, Nutramax Laboratories, Inc..
The otc pet medication market is expected to grow at a compound annual growth rate of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 OTC Pet Medication Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 OTC Pet Medication Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 OTC Pet Medication Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the OTC Pet Medication Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global OTC Pet Medication Market Size & Forecast, 2018-2028
4.5.1 OTC Pet Medication Market Size and Y-o-Y Growth
4.5.2 OTC Pet Medication Market Absolute $ Opportunity
Chapter 5 Global OTC Pet Medication Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 OTC Pet Medication Market Size Forecast by Type
5.2.1 Fleas & Ticks Removal
5.2.2 Pain Relief & Arthritis
5.2.3 Dewormers
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global OTC Pet Medication Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 OTC Pet Medication Market Size Forecast by Applications
6.2.1 Dogs & Cats
6.2.2 Birds
6.2.3 Fish & Reptiles
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global OTC Pet Medication Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 OTC Pet Medication Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America OTC Pet Medication Analysis and Forecast
9.1 Introduction
9.2 North America OTC Pet Medication Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America OTC Pet Medication Market Size Forecast by Type
9.6.1 Fleas & Ticks Removal
9.6.2 Pain Relief & Arthritis
9.6.3 Dewormers
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America OTC Pet Medication Market Size Forecast by Applications
9.10.1 Dogs & Cats
9.10.2 Birds
9.10.3 Fish & Reptiles
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe OTC Pet Medication Analysis and Forecast
10.1 Introduction
10.2 Europe OTC Pet Medication Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe OTC Pet Medication Market Size Forecast by Type
10.6.1 Fleas & Ticks Removal
10.6.2 Pain Relief & Arthritis
10.6.3 Dewormers
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe OTC Pet Medication Market Size Forecast by Applications
10.10.1 Dogs & Cats
10.10.2 Birds
10.10.3 Fish & Reptiles
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific OTC Pet Medication Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific OTC Pet Medication Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific OTC Pet Medication Market Size Forecast by Type
11.6.1 Fleas & Ticks Removal
11.6.2 Pain Relief & Arthritis
11.6.3 Dewormers
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific OTC Pet Medication Market Size Forecast by Applications
11.10.1 Dogs & Cats
11.10.2 Birds
11.10.3 Fish & Reptiles
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America OTC Pet Medication Analysis and Forecast
12.1 Introduction
12.2 Latin America OTC Pet Medication Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America OTC Pet Medication Market Size Forecast by Type
12.6.1 Fleas & Ticks Removal
12.6.2 Pain Relief & Arthritis
12.6.3 Dewormers
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America OTC Pet Medication Market Size Forecast by Applications
12.10.1 Dogs & Cats
12.10.2 Birds
12.10.3 Fish & Reptiles
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) OTC Pet Medication Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) OTC Pet Medication Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) OTC Pet Medication Market Size Forecast by Type
13.6.1 Fleas & Ticks Removal
13.6.2 Pain Relief & Arthritis
13.6.3 Dewormers
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) OTC Pet Medication Market Size Forecast by Applications
13.10.1 Dogs & Cats
13.10.2 Birds
13.10.3 Fish & Reptiles
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 OTC Pet Medication Market: Competitive Dashboard
14.2 Global OTC Pet Medication Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bayer Companion Animal
14.3.2 Boehringer Ingelheim Animal Health
14.3.3 Ceva Sante Animale
14.3.4 Merck Inc.
14.3.5 Zoetis Inc.
14.3.6 Elanco
14.3.7 Virbac SA
14.3.8 Vetoquinol SA
14.3.9 Frontline
14.3.10 Zymox
14.3.11 ChloraSeb
14.3.12 Sulfox
14.3.13 Adequan
14.3.14 Dechra Pharmaceuticals PLC
14.3.15 Nutramax Laboratories, Inc.
